dihexa calculated logp Total Health Solutions DIHEXA Research Compound Capsules -
Description
Using co-immunoprecipitation (CO-IP), the study confirmed that FOXO4-DRI prevents FOXO4 binding to p53, facilitating phosphorylated p53 nuclear exclusion, which triggers BAX upregulation and cleaved caspase-3 activation driving selective apoptosis of senescent endothelial cells
Taking doses on an empty stomach, at least 30 minutes before meals or 2 hours after, optimizes gastric conditions for the delayed release mechanism
PMID 10198757
Mushroom peptides visibly reduce fine lines & textured skin creating smoother, younger-looking skin
